Today: 29 April 2026
Browse Category

NYSE:LEU 25 September 2025 - 16 March 2026

Oklo Stock Heads Into Q4 Earnings as Meta Deal Fuels Bulls, but Risks Pile Up

Oklo Stock Heads Into Q4 Earnings as Meta Deal Fuels Bulls, but Risks Pile Up

Oklo shares rose Monday ahead of its fourth-quarter results, with the stock trading at $58.60, down nearly 70% from its 52-week high. The company will report full-year 2025 results after markets close Tuesday, with Wall Street expecting a quarterly loss of 17 cents per share. Oklo recently announced a joint venture with Centrus Energy for HALEU fuel in Ohio and secured a development agreement with Meta for a 1.2-gigawatt power campus.
16 March 2026
····
Palantir Stock Price Falls as Nvidia Pact, New AI Deals Face Wall Street Test

Palantir Stock Price Falls as Nvidia Pact, New AI Deals Face Wall Street Test

Palantir shares fell 2.7% to $149.41 Friday, underperforming U.S. stocks, after announcing new AI and defense partnerships at its AIPCon event, including a software deal with Nvidia. The stock is down nearly 14% for 2026 despite a 92% gain over the past year. Palantir faces fallout from the Pentagon’s break with Anthropic, which supplied code for its Maven Smart System military platform.
13 March 2026
······
Centrus Energy stock price jumps 8% before MLK Day break — what traders watch next for LEU

Centrus Energy stock price jumps 8% before MLK Day break — what traders watch next for LEU

Centrus Energy shares rose 8.1% Friday to $331.03 after landing a $900 million Department of Energy contract to expand uranium enrichment in Ohio. The deal is part of a $2.7 billion federal push to boost domestic supply. U.S. uranium spot prices are forecast to reach $82 a pound by late 2025, while domestic mine output remains far below demand. Centrus reports quarterly earnings Feb. 5.
18 January 2026
··
NuScale Power stock jumps 15% to start 2026 as nuclear names rally — what to watch Monday

NuScale Power stock jumps 15% to start 2026 as nuclear names rally — what to watch Monday

NuScale Power shares jumped 15.1% to $16.31 Friday on heavy volume, tracking gains across nuclear stocks and uranium ETFs. Oklo, Centrus Energy, and BWX Technologies also rose. Finland’s Olkiluoto 2 nuclear unit was resynchronized to the grid after a 17-hour shutdown during a software update. The U.S. Energy Department in December pledged up to $800 million for small modular reactor projects.
4 January 2026
····
Centrus Energy Stock (LEU) News: DOE Enrichment Catalysts, Analyst Targets, and What to Watch Before Monday’s Open

Centrus Energy Stock (LEU) News: DOE Enrichment Catalysts, Analyst Targets, and What to Watch Before Monday’s Open

Centrus Energy shares closed Friday at $254.30, down 2.26%, and slipped further in after-hours trading. The company announced it has started domestic centrifuge manufacturing for commercial uranium enrichment at its Ohio facility, with first capacity expected in 2029. Centrus is a finalist for Department of Energy contracts potentially worth $900 million each.
27 December 2025
··
Centrus Energy Corp (LEU) Stock Jumps on Dec. 19, 2025 as It Starts U.S. Centrifuge Manufacturing for Uranium Enrichment Expansion

Centrus Energy Corp (LEU) Stock Jumps on Dec. 19, 2025 as It Starts U.S. Centrifuge Manufacturing for Uranium Enrichment Expansion

Centrus Energy shares rose about 11% to $255 on December 19 after the company announced it has started manufacturing centrifuges in Ohio for commercial low-enriched uranium enrichment. The company cited a $2.3 billion contingent sales backlog and expects new capacity online in 2029. Centrus also reported over $1.6 billion in cash and detailed recent and potential funding sources. The update was filed with the SEC.
19 December 2025
·
Centrus Energy’s Multi-Billion Nuclear Bet Pays Off – LEU Stock Skyrockets on Uranium Boom

Centrus Energy’s Multi-Billion Nuclear Bet Pays Off – LEU Stock Skyrockets on Uranium Boom

Centrus Energy shares surged over 500% year-on-year, hitting a 52-week high of $265.48 in September 2025, with market cap near $5 billion. On Sept. 25, the company announced a multi-billion-dollar expansion of its Ohio uranium plant, pending federal funding. Centrus reported Q2 net income of $28.9 million and a $3.6 billion order backlog. Analysts remain split on valuation, with price targets ranging from $108 to $310.
25 September 2025
·

Stock Market Today

  • Energean Shifts Investment Outlook with New Angola Deal and Updated Price Targets
    April 29, 2026, 1:31 PM EDT. Energean's central fair value estimate nudged from £9.24 to £9.30, reflecting analyst adjustments amid evolving risks. Berenberg reduced price targets by 75 GBp and 15 GBp, citing concerns over project execution and valuation. Jefferies downgraded Energean in February, signaling caution over its risk-reward balance. Notably, Energean secured the safe restart of its Power FPSO vessel, resuming production after a temporary suspension due to geopolitical tensions in early 2026. The company also agreed to acquire Chevron's interests in offshore Angola blocks for US$260 million plus contingent payments, aiming to boost output and reserves. Investors face execution and valuation risks but gain fresh growth impetus from the Angola acquisition, positioning Energean at a pivotal point for portfolio consideration.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Go toTop